ZA956139B - New process for the production of biologically active protein - Google Patents

New process for the production of biologically active protein

Info

Publication number
ZA956139B
ZA956139B ZA956139A ZA956139A ZA956139B ZA 956139 B ZA956139 B ZA 956139B ZA 956139 A ZA956139 A ZA 956139A ZA 956139 A ZA956139 A ZA 956139A ZA 956139 B ZA956139 B ZA 956139B
Authority
ZA
South Africa
Prior art keywords
biologically active
production
new process
active protein
beta
Prior art date
Application number
ZA956139A
Other languages
English (en)
Inventor
Nico Cerletti
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of ZA956139B publication Critical patent/ZA956139B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA956139A 1994-07-25 1995-07-24 New process for the production of biologically active protein ZA956139B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94810439 1994-07-25

Publications (1)

Publication Number Publication Date
ZA956139B true ZA956139B (en) 1996-03-07

Family

ID=8218293

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA956139A ZA956139B (en) 1994-07-25 1995-07-24 New process for the production of biologically active protein

Country Status (19)

Country Link
US (1) US7057016B2 (xx)
EP (1) EP0779896B1 (xx)
JP (2) JPH11505404A (xx)
KR (1) KR100394532B1 (xx)
AT (1) ATE207934T1 (xx)
AU (1) AU699879B2 (xx)
CA (1) CA2194578A1 (xx)
DE (1) DE69523611T2 (xx)
DK (1) DK0779896T3 (xx)
ES (1) ES2166402T3 (xx)
FI (1) FI118385B (xx)
HU (1) HU222829B1 (xx)
IL (1) IL114702A (xx)
NO (1) NO317730B1 (xx)
NZ (1) NZ290374A (xx)
PT (1) PT779896E (xx)
TW (1) TW517059B (xx)
WO (1) WO1996003433A1 (xx)
ZA (1) ZA956139B (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997023638A1 (fr) * 1995-12-21 1997-07-03 Ajinomoto Co., Inc. Procede pour replier l'activine a humaine
DE10026713A1 (de) * 2000-05-30 2001-12-06 Walter Sebald Mutein einer Kette eines Proteins aus der Superfamilie des Wachstumsfaktors TGF-beta
US20030134292A1 (en) * 2001-10-30 2003-07-17 Farchaus Joseph W. Thermostable DNA polymerases and methods of making same
FR2871061B1 (fr) * 2004-06-04 2007-08-10 Coletica Sa Principe actif capable d'induire la transformation du tgbf- latent inactif en tgfb actif
US7572474B2 (en) * 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8075934B2 (en) * 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
WO2007033082A2 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Compositions comprising dimethyl sulfoxide (dmso)
US8435224B2 (en) 2005-09-12 2013-05-07 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (DMSO) and related compounds
AU2006291134C1 (en) 2005-09-12 2013-08-15 Abela Pharmaceuticals, Inc. Systems for removing dimethyl sulfoxide (DMSO) or related compounds, or odors associated with same
US8480797B2 (en) 2005-09-12 2013-07-09 Abela Pharmaceuticals, Inc. Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
GB0604966D0 (en) * 2006-03-11 2006-04-19 Renovo Ltd Medicaments and proteins
US8986769B2 (en) 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
BRPI0921494A2 (pt) 2008-11-03 2018-10-30 Prad Reasearch And Development Ltd método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
US9839609B2 (en) 2009-10-30 2017-12-12 Abela Pharmaceuticals, Inc. Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat osteoarthritis
US10647777B2 (en) * 2014-05-28 2020-05-12 Genzyme Corporation Methods of controlling the formation of disulfide bonds in protein solutions
JP2016183118A (ja) * 2015-03-25 2016-10-20 東ソー株式会社 増殖因子前駆体のリフォールディング方法
CN110382523B (zh) 2016-12-30 2024-04-16 博晟生医股份有限公司 重组多肽及其组合物及方法
WO2023064747A1 (en) * 2021-10-11 2023-04-20 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Engineered tgf-beta monomers and methods of use
GB2616476A (en) * 2022-03-11 2023-09-13 Multus Biotechnology Ltd Recombinant transforming growth factor beta 3 in yeast

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0051985B2 (en) * 1980-11-07 1989-12-27 International Institute Of Cellular And Molecular Pathology (Icp) Immunoassay of proteins
US4620948A (en) 1982-12-22 1986-11-04 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
GR79124B (xx) 1982-12-22 1984-10-02 Genentech Inc
DE3587022T2 (de) 1984-02-17 1993-06-17 Genentech Inc Menschlicher transformationswachstumsfaktor und vorlaeufer oder fragment hiervon, zellen, dna, vektoren und verfahren zu ihrer herstellung, zusammensetzungen und produkte, die diese enthalten, sowie davon abgeleitete antikoerper und diagnostizierverfahren.
US4572798A (en) 1984-12-06 1986-02-25 Cetus Corporation Method for promoting disulfide bond formation in recombinant proteins
US4731440A (en) 1985-02-22 1988-03-15 Monsanto Company Method of somatotropin solubilization using dimethylsulfone and naturation
IL78197A (en) 1985-03-22 1991-07-18 Genentech Inc Nucleic acid encoding tgf-beta and its uses
GB8508340D0 (en) 1985-03-29 1985-05-09 Creighton T E Production of protein
EP0208539A3 (en) 1985-07-11 1988-08-03 Repligen Corporation Folding disulfide-cross-linkable proteins
US5453363A (en) 1985-10-23 1995-09-26 Boehringer Mannheim Gmbh Process for the activation of t-PA or Ing after genetic expression in prokaryotes
JPH0759598B2 (ja) * 1986-02-14 1995-06-28 藤沢薬品工業株式会社 ヒトインスリン様成長因子▲ｉ▼の製造法
NZ222168A (en) 1986-10-20 1991-05-28 Oncogene Science Inc Tumour growth inhibiting protein related to tgf-#b#1 and tgf-#b#2, preparation by genetic engineering methods, antibodies and pharmaceutical compositions
WO1988003807A2 (en) 1986-11-17 1988-06-02 Sandoz Ag Production and use of a novel t-cell suppressor factor
FI100106B (fi) 1986-12-05 1997-09-30 Novartis Ag Menetelmä plasminogeenin yksisäikeisen yhdistelmäaktivaattorin valmist amiseksi
US4931548A (en) 1987-01-30 1990-06-05 Techne Corporation Heterodimer form of transforming growth factor-beta
IL86090A (en) 1987-04-16 1993-03-15 Cetus Oncology Corp Production of purified, biologically active, bacterially produced recombinant human csf-1
US5162507A (en) 1987-05-11 1992-11-10 Cetus Corporation Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms
AU622860B2 (en) 1987-05-11 1992-04-30 Novartis Vaccines And Diagnostics, Inc. Process for recovering purified, oxidized, renatured recombinant interleukin-2 from microorganisms
AU626524B2 (en) * 1987-05-29 1992-08-06 Bristol-Myers Squibb Company Cloning and expression of simian transforming growth factor- beta 1
US4985544A (en) 1987-08-04 1991-01-15 Kyowa Hakko Kogyo Co., Ltd. Process for renaturing fish growth hormone
US5061786A (en) * 1989-05-25 1991-10-29 Genentech, Inc. Biologically active polypeptides based on transforming growth factor-β
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
US5843463A (en) * 1990-12-21 1998-12-01 Antexbiologics, Inc. Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae
US5144006A (en) * 1991-06-13 1992-09-01 The Rockefeller University Oxidative folding of peptide and protein substrates using hydrocarbon sulfoxides
AU2738392A (en) * 1991-11-11 1993-05-13 Ciba-Geigy Ag Novel hybrid transforming growth factors
US5407810A (en) * 1993-08-20 1995-04-18 Genentech, Inc. Aqueous multiple-phase isolation of polypeptide
TW440566B (en) * 1994-07-25 2001-06-16 Novartis Ag Novel process for the production of biologically active dimeric protein

Also Published As

Publication number Publication date
PT779896E (pt) 2002-03-28
FI970258A0 (fi) 1997-01-22
CA2194578A1 (en) 1996-02-08
JPH11505404A (ja) 1999-05-21
NO317730B1 (no) 2004-12-13
HU222829B1 (hu) 2003-11-28
HUT76667A (en) 1997-10-28
IL114702A0 (en) 1995-11-27
FI118385B (fi) 2007-10-31
JP4354980B2 (ja) 2009-10-28
DE69523611T2 (de) 2002-06-20
EP0779896A1 (en) 1997-06-25
DK0779896T3 (da) 2002-02-18
ES2166402T3 (es) 2002-04-16
EP0779896B1 (en) 2001-10-31
US7057016B2 (en) 2006-06-06
WO1996003433A1 (en) 1996-02-08
DE69523611D1 (de) 2001-12-06
JP2007082554A (ja) 2007-04-05
TW517059B (en) 2003-01-11
FI970258A (fi) 1997-01-22
NO970326D0 (no) 1997-01-24
NZ290374A (en) 1998-07-28
NO970326L (no) 1997-01-24
AU699879B2 (en) 1998-12-17
KR100394532B1 (ko) 2003-10-22
AU3109695A (en) 1996-02-22
US20020115834A1 (en) 2002-08-22
IL114702A (en) 2005-03-20
ATE207934T1 (de) 2001-11-15

Similar Documents

Publication Publication Date Title
ZA956139B (en) New process for the production of biologically active protein
IL114701A (en) Process for the production of biologically active dimeric transforming growth factor
WO1998007745A3 (en) Compositions and methods for treating infections using analogues of indolicidin
GB2302329B (en) Yeast strains
HU895836D0 (en) Process for the preparation of carrier proteins
ZA927993B (en) A colostrum fraction, a process of preparing it and its use.
BG103219A (en) Benzamidine derivatives and their application as medicamentous forms with ltb-4-antagonist effect
EP0695801A3 (en) Peptide compositions derived from yeast proteins, process for their preparation and their uses
AU4683489A (en) Tgf-beta 1/beta 2: a novel chimeric transforming growth factor-beta
MX9702665A (es) Analogos del factor de crecimiento de queratinocitos.
ZA934037B (en) Novel biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same.
MX9700657A (es) Nuevo proceso para la produccion de proteina biologicamente activa.
MX9700656A (es) Proceso novedoso para la produccion de proteina dimerica biologicamente activa.
PL355852A1 (en) Fragments of virus protein vp2 or 3 of the polyoma virus, used for transporting active ingredients
EP0281089A3 (en) Process for the preparation of factor viii:c deficient plasma, and deficient plasma obtained therwith
DK0454739T3 (da) Fremgangsmåde til isolering af oprenset EPI protein fra en opløsning, især en fermenteringsopløsning
WO1997041207A3 (en) Expression of soluble heterologous proteins in bacteria utilizing a thioredoxin/protein expression vector